PX P10, Inc.

NYSE p10alts.com


$ 10.83 $ 0.13 (1.22 %)    

Wednesday, 15-Oct-2025 15:59:53 EDT
QQQ $ 605.89 $ 0.00 (0 %)
DIA $ 463.87 $ 0.00 (0 %)
SPY $ 668.00 $ 0.00 (0 %)
TLT $ 90.87 $ 0.00 (0 %)
GLD $ 390.50 $ 0.00 (0 %)
$ 10.82
$ 10.80
$ 9.27 x 2,000
$ 11.73 x 450
-- - --
$ 8.79 - $ 14.15
295,649
na
1.19B
$ 0.51
$ 81.48
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-08-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-13-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-27-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-18-2022 12-31-2021 10-K
16 11-22-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 p10-inc-announces-dual-listing-of-its-class-a-common-stock-on-nyse-texas-effective-august-15-2025

P10, Inc. (NYSE:PX), a leading private markets solutions provider, today announced a dual listing of its Class A common stock o...

 p10-q2-adj-eps-023-beats-020-estimate-sales-72704m-beat-71250m-estimate

P10 (NYSE:PX) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 13.3 percent...

 oppenheimer-maintains-outperform-on-p10-raises-price-target-to-21

Oppenheimer analyst Chris Kotowski maintains P10 (NYSE:PX) with a Outperform and raises the price target from $20 to $21.

 jp-morgan-maintains-overweight-on-p10-lowers-price-target-to-145

JP Morgan analyst Kenneth Worthington maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $15 to $14.5.

 barclays-maintains-overweight-on-p10-raises-price-target-to-14

Barclays analyst Benjamin Budish maintains P10 (NYSE:PX) with a Overweight and raises the price target from $13 to $14.

 p10-q1-adj-eps-020-misses-021-estimate-sales-6767m-miss-6947m-estimate

P10 (NYSE:PX) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.21 by 4.76 perce...

 morgan-stanley-maintains-equal-weight-on-p10-lowers-price-target-to-12

Morgan Stanley analyst Michael Cyprys maintains P10 (NYSE:PX) with a Equal-Weight and lowers the price target from $14 to $12.

 wall-street-eyes-recovery-as-sp-500-nasdaq-futures-rise-after-trumps-tariff-driven-selloff-wipes-out-9-trillion-in-six-weeks

U.S. stock futures rose on Tuesday following a volatile day of trading on Monday that led the indices to close on a mixed note.

 barclays-maintains-overweight-on-p10-lowers-price-target-to-13

Barclays analyst Benjamin Budish maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $15 to $13.

 stephens--co-maintains-overweight-on-p10-raises-price-target-to-16

Stephens & Co. analyst John Campbell maintains P10 (NYSE:PX) with a Overweight and raises the price target from $13 to $16.

 barclays-maintains-overweight-on-p10-lowers-price-target-to-15

Barclays analyst Benjamin Budish maintains P10 (NYSE:PX) with a Overweight and lowers the price target from $16 to $15.

 p10-q4-adj-eps-030-beats-026-estimate-sales-8501m-beat-7386m-estimate

P10 (NYSE:PX) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.26 by 15.38 percen...

 barclays-maintains-overweight-on-p10-raises-price-target-to-16

Barclays analyst Benjamin Budish maintains P10 (NYSE:PX) with a Overweight and raises the price target from $15 to $16.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION